Overall , @ ( @ % ) of @ patients completed the study ( BRV : @ % , @ % , and @ % for @ , @ , and @ mg/day , respectively ; PBO : @ % ) and @ ( @ % ) of @ patients continued into long-term follow-up studies ( BRV : @ % , @ % , and @ % for @ , @ , and @ mg/day , respectively ; PBO : @ % ) .